Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Acceleration of chronic myeloproliferation by enforced expression of Meis1 or Meis3 in Icsbp-deficient bone marrow cells

Abstract

Identifying genetic pathways that cooperate in leukemogenesis facilitates our understanding of the molecular mechanisms at play. Interferon consensus sequence-binding protein (ICSBP) is a tumor suppressor, whose downregulation cooperates with BCR-ABL and NUP98-TOP1 gene products to accelerate leukemia induction in mouse models. Similarly, Meis1 synergizes with HoxA9 or NUP98-HOX (but not NUP98-TOP1) fusion genes to promote the early onset of leukemia. To investigate whether Icsbp deficiency interacts with Meis1 or its family member Meis3, we transplanted Icsbp−/− bone marrow (BM) cells after transduction with Meis1 or Meis3 retroviral vectors. Here, we show that enforced expression of Meis1 or Meis3 in Icsbp−/− BM cells induces a fatal, invasive myeloproliferative disease. Secondary mutations, such as activation of Mn1, led to the progression to acute myeloid leukemia in a few mice. Interestingly, expression of endogenous Meis1 and Meis3 mRNAs was repressed in the granulocytic progenitor population of Icsbp−/− mice. These results reveal a novel collaboration between Icsbp deficiency and Meis1/Meis3 in the acceleration of chronic myeloid leukemia-like disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Burchert A, Cai D, Hofbauer LC, Samuelsson MK, Slater EP, Duyster J et al. (2004). Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2. Blood 103: 3480–3489.

    Article  CAS  Google Scholar 

  • Diaz-Blanco E, Bruns I, Neumann F, Fischer JC, Graef T, Rosskopf M et al. (2007). Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia 21: 494–504.

    Article  CAS  Google Scholar 

  • Gabriele L, Phung J, Fukumoto J, Segal D, Wang IM, Giannakakou P et al. (1999). Regulation of apoptosis in myeloid cells by interferon consensus sequence-binding protein. J Exp Med 190: 411–421.

    Article  CAS  Google Scholar 

  • Gurevich RM, Rosten PM, Schwieger M, Stocking C, Humphries RK . (2006). Retroviral integration site analysis identifies ICSBP as a collaborating tumor suppressor gene in NUP98-TOP1-induced leukemia. Exp Hematol 34: 1192–1201.

    Article  CAS  Google Scholar 

  • Hao SX, Ren R . (2000). Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder. Mol Cell Biol 20: 1149–1161.

    Article  CAS  Google Scholar 

  • Holtschke T, Lohler J, Kanno Y, Fehr T, Giese N, Rosenbauer F et al. (1996). Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87: 307–317.

    Article  CAS  Google Scholar 

  • Kelly LM, Gilliland DG . (2002). Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet 3: 179–198.

    Article  CAS  Google Scholar 

  • Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G . (1998). Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J 17: 3714–3725.

    Article  CAS  Google Scholar 

  • Kroon E, Thorsteinsdottir U, Mayotte N, Nakamura T, Sauvageau G . (2001). NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice. EMBO J 20: 350–361.

    Article  CAS  Google Scholar 

  • Lawrence HJ, Rozenfeld S, Cruz C, Matsukuma K, Kwong A, Komuves L et al. (1999). Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias. Leukemia 13: 1993–1999.

    Article  CAS  Google Scholar 

  • Moskow JJ, Bullrich F, Huebner K, Daar IO, Buchberg AM . (1995). Meis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 mice. Mol Cell Biol 15: 5434–5443.

    Article  CAS  Google Scholar 

  • Nakamura T, Jenkins NA, Copeland NG . (1996). Identification of a new family of Pbx-related homeobox genes. Oncogene 13: 2235–2242.

    CAS  PubMed  Google Scholar 

  • Pineault N, Abramovich C, Ohta H, Humphries RK . (2004). Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1. Mol Cell Biol 24: 1907–1917.

    Article  CAS  Google Scholar 

  • Pineault N, Buske C, Feuring-Buske M, Abramovich C, Rosten P, Hogge DE et al. (2003). Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1. Blood 101: 4529–4538.

    Article  CAS  Google Scholar 

  • Scheller M, Foerster J, Heyworth CM, Waring JF, Lohler J, Gilmore GL et al. (1999). Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein. Blood 94: 3764–3771.

    CAS  PubMed  Google Scholar 

  • Schmidt M, Bies J, Tamura T, Ozato K, Wolff L . (2004). The interferon regulatory factor ICSBP/IRF-8 in combination with PU.1 up-regulates expression of tumor suppressor p15(Ink4b) in murine myeloid cells. Blood 103: 4142–4149.

    Article  CAS  Google Scholar 

  • Schmidt M, Hochhaus A, Nitsche A, Hehlmann R, Neubauer A . (2001a). Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-alpha. Blood 97: 3648–3650.

    Article  CAS  Google Scholar 

  • Schmidt M, Hoffmann G, Wissler M, Lemke N, Mussig A, Glimm H et al. (2001b). Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. Hum Gene Ther 12: 743–749.

    Article  CAS  Google Scholar 

  • Schmidt M, Nagel S, Proba J, Thiede C, Ritter M, Waring JF et al. (1998). Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood 91: 22–29.

    CAS  PubMed  Google Scholar 

  • Schwieger M, Lohler J, Friel J, Scheller M, Horak I, Stocking C . (2002). AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency. J Exp Med 196: 1227–1240.

    Article  CAS  Google Scholar 

  • Serrano E, Lasa A, Perea G, Carnicer MJ, Brunet S, Aventin A et al. (2006). Acute myeloid leukemia subgroups identified by pathway-restricted gene expression signatures. Acta Haematol 116: 77–89.

    Article  CAS  Google Scholar 

  • Slape C, Hartung H, Lin YW, Bies J, Wolff L, Aplan PD . (2007). Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation. Cancer Res 67: 5148–5155.

    Article  CAS  Google Scholar 

  • Turcotte K, Gauthier S, Tuite A, Mullick A, Malo D, Gros P . (2005). A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice. J Exp Med 201: 881–890.

    Article  CAS  Google Scholar 

  • Wang GG, Pasillas MP, Kamps MP . (2006). Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes. Mol Cell Biol 26: 3902–3916.

    Article  CAS  Google Scholar 

  • Zhu C, Saberwal G, Lu Y, Platanias LC, Eklund EA . (2004). The interferon consensus sequence-binding protein activates transcription of the gene encoding neurofibromin 1. J Biol Chem 279: 50874–50885.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Drs T Nakamura (Japanese Foundation for Cancer Research) and T Kitamura (Institute of Medical Science, University of Tokyo) for Meis1a cDNA and pMYs-IG vectors, respectively. We also thank Susanne Roscher and Silvia Dolski for assistance. This study was supported by the Human Science Foundation, the Ministry of Education, Culture, Sports, Science and Technology of Japan and the German José Carrreras Leukemia Foundation. The Heinrich-Pette-Institut is supported by the Freie und Hansestadt Hamburg and the Federal Ministry of Health and Social Security.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T Hara.

Additional information

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hara, T., Schwieger, M., Kazama, R. et al. Acceleration of chronic myeloproliferation by enforced expression of Meis1 or Meis3 in Icsbp-deficient bone marrow cells. Oncogene 27, 3865–3869 (2008). https://doi.org/10.1038/sj.onc.1211043

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1211043

Keywords

This article is cited by

Search

Quick links